It has also been shown that patients with neurodegenerative diseases like Alzheimer’s, Huntington’s, and amyotrophic lateral sclerosis have significantly higher concentrations of CCL11 in their serum or CSF. This evidence concerns the gene CCL11 and amyotrophic lateral sclerosis.